Literature DB >> 9285692

v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.

W X Zong1, M Farrell, J Bash, C Gélinas.   

Abstract

The v-Rel oncoprotein belongs to the Rel/NF-kappaB family of transcription factors. It transforms chicken lymphoid cells in vitro and induces fatal lymphomas in vivo. In this study, we used a tetracycline-regulated system to characterize the role of v-Rel in cell transformation. We show that the continued expression of v-Rel is necessary to maintain the viability of transformed lymphoid cells and enables primary spleen cells to escape apoptosis in vitro culture. In agreement with a possible role for v-Rel in the inhibition of programmed cell death, its inducible expression in HeLa cells prevented TNFalpha-induced apoptosis. While the repression of v-Rel was accompanied by the rapid degradation of IkappaBalpha, changes in the steady-state levels of the apoptosis inhibitors Bcl-2 and Bcl-X(L) were only observed following the onset of cell death in transformed lymphoid cells. This suggests that the anti-apoptotic activity of v-Rel may affect other apoptosis inhibitors or other factors in the death pathway. Together, these findings demonstrate that v-Rel blocks apoptosis and suggest that this activity may be an important component of its transforming function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285692     DOI: 10.1038/sj.onc.1201266

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 2.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

Authors:  J Bash; W X Zong; C Gélinas
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

Authors:  Jarmila Kralova; Andrew S Liss; William Bargmann; Cullen Pendleton; Janani Varadarajan; Emin Ulug; Henry R Bose
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

Authors:  C Chen; L C Edelstein; C Gélinas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.

Authors:  W X Zong; L C Edelstein; C Chen; J Bash; C Gélinas
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

7.  Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.

Authors:  C Chen; F Agnès; C Gélinas
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 8.  TNF-induced signaling in apoptosis.

Authors:  P C Rath; B B Aggarwal
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.542

9.  Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production.

Authors:  K Ruckdeschel; S Harb; A Roggenkamp; M Hornef; R Zumbihl; S Köhler; J Heesemann; B Rouot
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

10.  The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins.

Authors:  Zulfiqar F Cheema; Daniel R Santillano; Stephen B Wade; Joseph M Newman; Rajesh C Miranda
Journal:  BMC Neurosci       Date:  2004-03-23       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.